LIVE
⭐7.9M influencer listings 🏢92.7K sponsor listings 🌍114.9B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋3.3M Bluesky creators 🎙️1.4M podcast creators 🟣1.2M Twitch creators 📈635.8K Pinterest creators 🥊290.1K Kick creators 𝕏242.8K X creators 239.4K YouTube creators 🐘238.7K Mastodon creators 🎵124.5K TikTok creators ✈️105.7K Telegram creators 🎮13.2K Discord creators 📈9.8K Substack creators 🎬4.6K Rumble creators 🧵3.4K Threads creators ⭐7.9M influencer listings 🏢92.7K sponsor listings 🌍114.9B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋3.3M Bluesky creators 🎙️1.4M podcast creators 🟣1.2M Twitch creators 📈635.8K Pinterest creators 🥊290.1K Kick creators 𝕏242.8K X creators 239.4K YouTube creators 🐘238.7K Mastodon creators 🎵124.5K TikTok creators ✈️105.7K Telegram creators 🎮13.2K Discord creators 📈9.8K Substack creators 🎬4.6K Rumble creators 🧵3.4K Threads creators
🧭 Explore 🌍 Top creators in United Kingdom Bluesky rankings
NEJM.org

NEJM.org✓ Add us as a preferred source on Google

Bluesky @nejm.org 📍 United Kingdom
⚔ Compare ☆ Follow Own this channel?
🔄 Data last refreshed 2 months ago
Followers
23.3K
Account age
1 yrs
🎁 Free analysisfor NEJM.org
🕵️Fake Followers CheckReal-audience % & bot risk→ 📊Engagement rateBenchmarked vs. peers→ 💰What they chargeFair sponsored-post price→

Known for

TALAPRO-3: Talazoparib–enzalutamide has been shown to improve survival in patients with metastatic prostate cancer, particularly those with alterations in homologous recombination repair genes. Research findings in this population are summarized in a new Quick Take video. https://nej.md/4fuadBY10 views TALAPRO-3: Talazoparib–enzalutamide has been shown to improve survival in patients with metastatic prostate cancer, particularly those with alterations in homologous recombination repair genes. Research findings in this population are summarized in a new Quick Take video. https://nej.md/4fuadBY Love watching @glaucomflecken.bsky.social explain research published in NEJM? If so, then good news! He and his fellow anchors have a new weekly news podcast called Medlines, designed to help everyone in health care stay in the know. Listen wherever you get your podcasts: medlinespod.com/follow.10 views Love watching @glaucomflecken.bsky.social explain research published in NEJM? If so, then good news! He and his fellow anchors have a new weekly news podcast called Medlines, designed to help everyone in health care stay in the know. Listen wherever you get your podcasts: medlinespod.com/follow. New in NEJM Voices: A patient in shock forced @iwashyna.bsky.social to consider how to respond to the limits of his own knowledge and those of the medical field at large. Read his latest: https://nej.md/4yVP1fO9 views New in NEJM Voices: A patient in shock forced @iwashyna.bsky.social to consider how to respond to the limits of his own knowledge and those of the medical field at large. Read his latest: https://nej.md/4yVP1fO Among 14 pregnancies in 13 patients with autoimmune disease who had undergone CAR T-cell therapy, early maternal and neonatal outcomes appeared reassuring, with no disease relapses reported and 8 healthy infants born to date. Read the full report: https://nej.md/4fM65Mv7 views Among 14 pregnancies in 13 patients with autoimmune disease who had undergone CAR T-cell therapy, early maternal and neonatal outcomes appeared reassuring, with no disease relapses reported and 8 healthy infants born to date. Read the full report: https://nej.md/4fM65Mv

📊 Post engagement

Recent posts · likes + reposts
Nov 30latest
5
Avg engagement / post
2–9
Typical post (engagement)
0%
Engagement vs followers
67/100
Consistent reach
Dec 2024
On Bluesky since
Half of recent posts land between 2 and 9 likes + reposts (median 4) — a dependable floor a sponsored post can count on.

🔥 Top post: TALAPRO-3: Talazoparib–enzalutamide has been shown to improve su · 10 likes + reposts

📊 Activity & format

Content mix
Mostly images
Recent: 0 text · 12 image · 0 video.
Follower / following
90×
Follows 260 back. A strong ratio — an audience that follows them, not a follow-for-follow network.

Recent posts

View on Bluesky ↗
🔥 Top post TALAPRO-3: Talazoparib–enzalutamide has been shown to improve survival in patients with metastatic prostate cancer, particularly those with alterations in homologous recombination repair genes. Research findings in this population are summarized in a new Quick Take video. https:… ★ 10
New in NEJM Voices: A patient in shock forced @iwashyna.bsky.social to consider how to respond to the limits of his own knowledge and those of the medical field at large. Read his latest: https://nej.md/4yVP1fO ★ 9 A 60-year-old man presented with a 1-month history of postprandial epigastric pain. The physical examination was normal, with no jaundice or abdominal tenderness observed. Read the full case details and submit your answer or see how othe… ★ 1 Want to gain a deeper understanding of the analyses and considerations that guide decisions about which articles to publish in NEJM? And insight and knowledge that will impact your career going forward? If so, consider applying for the 202… Love watching @glaucomflecken.bsky.social explain research published in NEJM? If so, then good news! He and his fellow anchors have a new weekly news podcast called Medlines, designed to help everyone in health care stay in the know. List… ★ 10 Many disorders that cause optic disk edema can produce retinal fluid and even macular exudates in a stellate pattern. The development of pronounced radial macular exudates, known as a macular star, suggests neuroretinitis. Learn more: http… ★ 1 A 45-year-old man presented with a 2-month history of worsening pain and swelling in his right shoulder. A radiograph showed destruction of the humeral head with a free-floating humeral diaphysis. Read the full case details: https://nej.md… ★ 1 New in NEJM: PARP Inhibition and ADT in Prostate Cancer (TALAPRO-3) Teclistamab in Previously Treated Multiple Myeloma (MajesTEC-9) Naᵥ1.8 Inhibitor for Acute Pain Iptacopan in IgA Nephropathy (APPLAUSE-IgAN) Explore the issue: ht… ★ 2 In a new NEJM Voices blog post, @paulsaxmd.bsky.social shares what cyclosporiasis outbreaks, past and present, can teach us. Learn more and sign up for email alerts: https://nej.md/4x7zAiL ★ 4 A new review summarizes platelet-activating anti–platelet factor 4 disorders, including heparin-induced thrombocytopenia and related syndromes, highlighting diagnosis, antibody mechanisms, and treatment strategies. Read the full review: ht… ★ 4 The selective Naᵥ1.8 inhibitor LTG-001 led to significantly greater reductions in pain scores than placebo over the course of 48 hours among patients who had moderate or severe pain after abdominoplasty. Full trial results: https://nej.md/… ★ 3 Among 14 pregnancies in 13 patients with autoimmune disease who had undergone CAR T-cell therapy, early maternal and neonatal outcomes appeared reassuring, with no disease relapses reported and 8 healthy infants born to date. Read the full… ★ 7

🦋 Handle & authenticity

✅ Domain-verified
@nejm.org
The handle is the domain nejm.org. On Bluesky a domain handle proves the owner controls that website — so this is verifiably the real nejm.org account, not an impersonator.
On Bluesky since
Dec 2024
Joined after Bluesky opened to the public — a settled account with a real history.

💡 Facts

🗓️Joined Bluesky in 2024 — 1 year ago.
👁️Averages 5 views per post.
🏅Earned the 10K Followers for passing 10K followers.
📍Based in United Kingdom.

🕵️ Fake follower check

Estimated
53/100
Fair Credibility score
76%
Mixed Real audience
Medium Fake-follower risk
High Data confidence
  • Est. 76% real, active audience · Medium fake-follower risk.
  • Low engagement (~0.0% of followers engage each post) — a sign of an inflated or inactive audience.
  • Organic base — far more followers than accounts it follows.
  • Verified account.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

About

Welcome to the official Bluesky account for the New England Journal of Medicine. Follow for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal, online at NEJM.org. Follow @ai.nejm.org for medical AI content.

📸 Gallery

New in NEJM Voices: A patient in shock forced @iwashyna.bsky.social to consider how to respond to the limits of his own knowledge and those of the medical field at large. Read his latest: https://nej.md/4yVP1fO A 60-year-old man presented with a 1-month history of postprandial epigastric pain. The physical examination was normal, with no jaundice or abdominal tenderness observed. Read the full case details and submit your answer or see how others responded: https://nej.md/IC07302026 Want to gain a deeper understanding of the analyses and considerations that guide decisions about which articles to publish in NEJM? And insight and knowledge that will impact your career going forward? If so, consider applying for the 2027–28 NEJM editorial fellowship. 👉 https://nej.md/3cCQajB TALAPRO-3: Talazoparib–enzalutamide has been shown to improve survival in patients with metastatic prostate cancer, particularly those with alterations in homologous recombination repair genes. Research findings in this population are summarized in a new Quick Take video. https://nej.md/4fuadBY Love watching @glaucomflecken.bsky.social explain research published in NEJM? If so, then good news! He and his fellow anchors have a new weekly news podcast called Medlines, designed to help everyone in health care stay in the know. Listen wherever you get your podcasts: medlinespod.com/follow. Many disorders that cause optic disk edema can produce retinal fluid and even macular exudates in a stellate pattern. The development of pronounced radial macular exudates, known as a macular star, suggests neuroretinitis. Learn more: https://nej.md/4wsAYMQ A 45-year-old man presented with a 2-month history of worsening pain and swelling in his right shoulder. A radiograph showed destruction of the humeral head with a free-floating humeral diaphysis. Read the full case details: https://nej.md/4wzHz8s New in NEJM: PARP Inhibition and ADT in Prostate Cancer (TALAPRO-3) Teclistamab in Previously Treated Multiple Myeloma (MajesTEC-9) Naᵥ1.8 Inhibitor for Acute Pain Iptacopan in IgA Nephropathy (APPLAUSE-IgAN) Explore the issue: https://nej.md/current-issue

🔀 Audience overlap

Estimated

Estimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.

Daniel Storey Daniel Storey 33% Eric Umansky Eric Umansky 17% MeidasmightyNurse MeidasmightyNurse 17% Jane Jane 13% Amber Sparks Amber Sparks 13% Sexual Harassment Panda Sexual Harassment Panda 12%

More like this

Find more →
Bluesky ＋
Daniel Storey
Daniel Storey ✓
@danielstorey85.bsky.social
23.3K Followers
Bluesky ＋
Sexual Harassment Panda
Sexual Harassment Panda
@cockmagic.bsky.social
23.3K Followers
Bluesky ＋
Jane
Jane
@plainjane2.bsky.social
23.3K Followers
Bluesky ＋
Eric Umansky
Eric Umansky
@ericumansky.bsky.social
23.3K Followers
Bluesky ＋
MeidasmightyNurse
MeidasmightyNurse
@nurselongeretta.bsky.social
23.3K Followers
Bluesky ＋
Amber Sparks
Amber Sparks
@ambersparks.bsky.social
23.3K Followers

Frequently asked questions

How much does NEJM.org charge for a sponsorship?
NEJM.org hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact NEJM.org for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify NEJM.org, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does NEJM.org have?
NEJM.org has 23,277 followers on Bluesky.

✉ Message NEJM.org

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

  • ✓ Message any influencer from their listing
  • ✓ The influencer gets notified by email
  • ✓ Manage every conversation in one inbox
See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with NEJM.org

Booking an event / appearance is a Pro feature. Upgrade to book NEJM.org for an in-person or virtual appearance — payment held safely in escrow until the event is done.

  • ✓ Book them for events, livestreams, panels & more
  • ✓ NEJM.org gets notified by email
  • ✓ Fee held in escrow, released after the appearance
See Pro $9.95/mo →

Already Pro? Log in.

Auto-generated from Bluesky's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove

✉️ Contact